Navigation Links
Anaheim to Host World's Largest Cystic Fibrosis Medical Meeting
Date:9/27/2007

More than 3,000 leading scientists and clinicians to present advances in CF research and care

ANAHEIM, Calif., Sept. 27 /PRNewswire-USNewswire/ --- An international medical meeting will draw more than 3,000 cystic fibrosis experts from all fields of science and medicine to Anaheim Oct. 3 - 6, 2007 to present the latest information and advances in cystic fibrosis drug research and care.

The 21st annual North American Cystic Fibrosis Conference is an annual ritual for leading CF research scientists and clinicians to collaborate in an open and noncompetitive environment. Key topics will include:

-- Advancements in drug discovery and development and the importance of

clinical trials;

-- Aztreonam lysine for inhalation as a potential new CF therapy;

-- Quality improvement and patient outcomes;

-- The importance of newborn screening; and

-- Serving the Hispanic CF population in the U.S.

Cystic fibrosis is a life-threatening genetic disease that affects approximately 30,000 children and adults in the United States. Ten million people are unknowing carriers of a CF gene. Fifty years ago, most children with CF died before reaching elementary school. Today, because of Cystic Fibrosis Foundation-supported drug research and care, people with CF are living to a median predicated age of 37.

WHAT: The 21st Annual North American Cystic Fibrosis Conference, the largest international gathering of leading cystic fibrosis research scientists and clinicians.

WHEN & WHERE:

Wed., Oct. 3 - Sat., Oct. 6, 2007 at the Anaheim Convention Center, Anaheim, Calif.

PLENARY SESSION HIGHLIGHTS:

-- Thursday, Oct. 4, 4:20 p.m. - "From Basic Science to the Clinic: Where

Are We & What Is Still Missing?" Margarida D. Amaral, Ph.D.,

University of Lisbon, Lisbon, Portugal.

-- Friday, Oct. 5, 8:30 a.m. - "CF Drug Development: What's New?" Felix

Ratjen, M.D., Ph.D., The Hospital for Sick
'/>"/>

SOURCE Cystic Fibrosis Foundation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Benefits Of The Worlds Most Widely Used Beverage
2. Worlds Largest Cord Blood Bank to be started in India
3. Australian Surgeons Successfully Conduct Worlds First Triple Organ Transplant
4. Worlds first mobile light surgery
5. Spanish Doctors Performs Worlds First Hand Transplantation Successfully
6. Worlds Heaviest Man Loses Weight Thanks to Monitored Dieting
7. Abu Dhabi to Have Worlds First Zero-carbon City
8. Eddie Murphy Voted Worlds Biggest Love-Rat
9. 3 die, 500 sickened in nations largest hepatitis A outbreak Associated Press
10. India Has The Oldest And Largest Collection Of Preserved Mosquitoes – Mosquito Museu
11. Heart Related Problems-The Largest Killers In Andhra Pradesh
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... , ... September 01, 2015 , ... September is Baby ... manufacturers use safety labels and stickers to keep little ones' safety top of mind ... Safety Month has a particular focus. According to the JPMA's Baby Safety Zone website, ...
(Date:8/31/2015)... ... September 01, 2015 , ... AthleticTraining.com, provider of CEUs for ... of new premium on-demand video Evidence Based Practice courses that ... 2014 must complete 50 CEUs before December 31, 2015, which must include at ...
(Date:8/31/2015)... ... August 31, 2015 , ... Sculpted Contours Luxury Medical ... Women of Power and Influence by Modern Luxury’s The Atlantan Magazine. , ... as well as Kathy King. Her idea and vision to bring to Atlanta ...
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... Southern Vacation ... – has teamed up with fellow South Walton property management company, 360 ... extreme poverty in remote parts of the world. The two companies will collect any ...
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... ... management, recently opened registration for the company’s second Introduction to Hyperbaric Medicine Course. ... October 15-18, 2015 aboard the Queen Mary Hotel in Long Beach, CA. The ...
Breaking Medicine News(10 mins):Health News:Lightning Labels Can Help Make A Difference This Baby Safety Month 2Health News:Lightning Labels Can Help Make A Difference This Baby Safety Month 3Health News:Evidence Based Practice Courses: CEUs For Athletic Trainers Just Released 2Health News:Sculpted Contours Owner Selected One of Atlanta's Women of Power and Influence by Modern Luxury's The Atlantan Magazine 2Health News:Sculpted Contours Owner Selected One of Atlanta's Women of Power and Influence by Modern Luxury's The Atlantan Magazine 3Health News:Southern Vacation Rentals Partners with the Sonder Project 2Health News:Southern Vacation Rentals Partners with the Sonder Project 3Health News:Registration Opens for Wound Care Advantage’s Second UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 2Health News:Registration Opens for Wound Care Advantage’s Second UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 3Health News:Registration Opens for Wound Care Advantage’s Second UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 4
... (NSAIDs), such as aspirin and ibuprofen, may reduce serum ... and hence may alter the detection of prostate cancer ... conclusion of a new study in the October 15, ... journal of the American Cancer Society. , Chronic ...
... and ibuprofen appear to lower a man,s PSA level, the ... a man is at risk of prostate cancer. , But ... in the journal Cancer , caution that men shouldn,t ... just yet. , "We showed that men who regularly ...
... also been linked recently to patient deaths , , ... once-a-week formulation of the injectable diabetes drug Byetta ... twice-a-day formulation, researchers report. , "Besides obvious improved ... remarkable advantage of both improved efficacy on glucose ...
... Pathologists Discuss the Latest Developments in Molecular,Testing and ... The practice of,pathology is at a transformation point. ... change the way patients are treated. Digital,slides and ... The College of American Pathologists is taking a ...
... ROCKVILLE, Md., Sept. 5 The Health Resources,and ... grants to,increase and improve medical services at the ... Bush,s historic expansion of the,health center network, whose ... Americans than ever before," HRSA,Administrator Elizabeth M. Duke ...
... Researchers explain how theoretical ,anti-cloak, could bring objects out ... Just in case someone develops a cloak of invisibility, ... to uncloak the objects it hides. , According to ... materials underneath an invisibility cloak would allow invisible objects ...
Cached Medicine News:Health News:Anti-inflammatory drugs may mask prostate cancer marker 2Health News:Common painkillers lower levels of prostate cancer biomarker 2Health News:Once-Weekly Diabetes Drug Boosts Blood Sugar Control 2Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2
(Date:8/31/2015)... 2015 Regen BioPharma, Inc. (OTCBB: RGBP) ... novel means of delivering its patented (US Patent ... tumors utilizing a clinically approved formulation as delivery ... with gene silencing therapeutics in which the gene ... whole body.  By utilizing a local delivery system, ...
(Date:8/31/2015)... and MOUNTAIN VIEW, Calif. , Aug. ... ; EURONEXT: SAN) and the life sciences team at ... care and outcomes for people with type 1 and ... treatments and devices with Google,s expertise in analytics, miniaturized ... explore how to improve diabetes care by developing new ...
(Date:8/31/2015)...  Qualcomm Incorporated (NASDAQ: QCOM ) today ... is collaborating with Davita Healthcare Partners and ... by Qualcomm Life,s 2net™ Device Connectivity Platform and ... informed interventions and better management of at-risk populations. ... Connect 2015 ecosystem conference taking place ...
Breaking Medicine Technology:Regen BioPharma, Inc. Develops BORIS Gene Silencing Based Treatment for Unresectable Liver Cancer 2Regen BioPharma, Inc. Develops BORIS Gene Silencing Based Treatment for Unresectable Liver Cancer 3Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 2Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 3Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 4Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 5Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 6Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 2Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 3Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 4Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 5
... 7, 2011  Tethys Bioscience has entered into an agreement ... employers measurably flatten the trajectory of their healthcare trends ... their employee populations. The agreement allows ACAP Health to ... as a component of its disease intervention programs. The ...
... 2011 Ampio Pharmaceuticals, Inc. (NASDAQ: AMPE ... and develops new uses for previously approved drugs and ... of the granting of a European patent with broad ... diketopiperazine which is the active ingredient of Ampion™.  The ...
Cached Medicine Technology:Tethys Bioscience and ACAP Health Consulting Partner to Help Employers Prevent Diabetes 2Tethys Bioscience and ACAP Health Consulting Partner to Help Employers Prevent Diabetes 3Ampio Pharmaceuticals Awarded European Patent that Strengthens Intellectual Property Protection for its key drug Ampion™ 2
Open blade design with aspiration capabilities for removing fluids from the operative site. 19 gauge wire....
Designed to provide open approaches of the keratome to the cornea for either the left or right eye. Lightweight wire design adds to the comfort of the instrument when in place....
Solid 14 mm free-swinging blades, suture posts, and stabilizing disk. Dull finish....
Designed for use with foster enucleation snare (E3670). Package of 12 stainless steel wires. Overall length 5.3 inches....
Medicine Products: